Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
Clinical Trials News- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Blogroll
-
Meta
Category Archives: Guest Blog
Patients Want to Talk. Do You?
Why are companies rushing to the web when traditional engagement with patient groups remains so under-exploited, asks Jacky Law.
It used to be so easy. Patients listened to doctors, doctors listened to pharma and everyone was happy. There was even a time when payers listened to pharma, reimbursing their prices with very few questions asked. Now [...]
Also posted in E-Media, Europe, FDA, Global, Legal Tagged patient communication, patient education, patient groups, Pharma, Regulatory, social media 1 Comment
HTA Concerns From European Drug Agency
The EMA’s Thomas Lönngren has gone public with his disquiet over organizations such as NICE. But pharma still needs more allies in fighting what it sees as the failings of the health technology assessment bodies, says Pharm Exec Europe’s Brussels correspondent, Reflector.
Europe’s pharmaceutical firms were never very keen on Britain’s influential National Institute for Health [...]
Also posted in Europe, Global, Regulatory, Safety, Strategy Tagged EU, European Medicines Agency, European Union, NICE, Regulatory Leave a comment
Do You Have a Head of Social Media?
And do you need one? Julian Upton looks at some of the contrasting ideas that emerged from last month’s Digital Pharma Europe event.
If anyone had any lingering doubts about an unprecedented era of inclusion and transparency promised by pharma’s newfound, if tentative, embrace of online social media, then last month’s Digital Pharma Europe conference must [...]
Also posted in E-Media, Europe, Events, Strategy, Technology Tagged corporate comminications, digital, Internet, online strategy, patient communications, social media 1 Comment

And What Exactly is a Stakeholder?